Cryptocurrency Sell-Off

Showing 342 articles
Business

Bitcoin vs. Ethereum: Navigating the Crypto Dip for Maximum Returns

As Bitcoin and Ethereum trade significantly below recent peaks, investors face a critical choice. While both present compelling opportunities, a deeper analysis of market dynamics, institutional sentiment, and long-term narratives suggests one digital asset may hold a decisive edge in the current cycle.

Business

AbCellera Biologics: A Tale of Two Valuations Amid Steep Share Decline

Shares of antibody discovery firm AbCellera Biologics plunged 16.8% last week, reigniting debate over its true worth. While a discounted cash flow model suggests deep undervaluation, its sky-high price-to-sales ratio paints a starkly different picture, leaving investors to navigate conflicting signals in a volatile biotech market.